The lysosomal disorder, TSD, is a GM2 gangliosidosis char-30 acterized by various symptoms such as seizures, blindness, 31 deafness, paralysis, and intellectual disability (Mahuran, 32 1999; Cachon-Gonzalez et al., 2018) . TSD is caused by a 33 mutation in the gene encoding HEXA, an enzyme that meta-34 bolizes GM2 to GM3 gangliosides in lysosomes, resulting in 35 deficient enzyme activity and GM2 ganglioside accumula-36 tion in the central nervous system (Mahuran, 1999; 37 Cachon-Gonzalez et al., 2018) that induces lysosomal 38 enlargement, one of the diagnostic markers for lysosomal 39 disease (Wenger et al., 2002 Q6 ). Prognosis is poor and the 40 neural dysfunction progresses without response to medica-41 tion (Cachon-Gonzalez et al., 2018) . There is no curative 42 therapy for TSD (Cachon-Gonzalez et al., 2018) .
43
Recently, a type of pluripotent stem cell known as iPSCs Taka-47 hashi and Yamanaka, 2006; Takahashi et al., 2007) . iPSCs 48 are multipotent in terms of differentiation and exhibit sus-49 tained growth in vitro (Takahashi and Yamanaka, 2006;  50 Takahashi et al., 2007) . Thus, because neural cells are dif-51 ficult to collect directly from patients, iPSCs from blood cells 52 can yield disease-derived neurons in vitro, and are thus 53 powerful tools for understanding the pathogenesis of dis-54 eases as well as for establishing in vitro disease models 55 (Kiskinis et al., 2014; Nieweg et al., 2015) . For example, a 56 previous study demonstrated that neural cells with 57 amyloid-beta accumulation displayed synaptic dysfunction 58 that elucidated a novel pathogenic pathway for Alzheimer's 59 disease (Nieweg et al., 2015) , while another study showed 60 that differentiated motor neurons derived from Amyotrophic
61
Lateral Sclerosis (ALS)-iPSC with a SUPEROXIDE DISMU-62 TASE (SOD) mutation mirrored some phenotypes such as 63 increased cell death due to oxidative stress and the degra-64 dation of mitochondrial function (Kiskinis et al., 2014) .
at the neuron level (Jadhav et al., 2005; Cachon-Gonzalez 70 et al., 2018) . Although TSD-iPSCs have been already 71 established, the study using them showed limited evidence 72 such as the enlargement of lysosomes (Vu et al., 2015; Liu 73 and Zhao, 2016 153, and 1018, respectively).
92
Human skin-derived fibroblasts were generated and isolated 
100
The iPSCs were then generated from the skin fibroblasts as 101 described previously (Fujie et al., 2014) . Briefly, the skin fibro-102 blasts were cultured in six-well plate (5 × 10 5 cells/well) with 103 Sendai virus (SeV) vectors at 10 multiplicity of infection for 104 7 days. Then infected fibroblasts were collected by trypsin 105 treatment and reseeded on mitomycin C (MMC)-treated mouse 106 embryonic fibroblast feeder cells (MEFs) in 60-mm dishes. To 107 prevent MEFs from the uncontrol proliferation, MEFs were trea-108 ted with 10 Q7 μg/ml MMC for 3 h before the use (MMC-treated 109 MEFs). Next day, the medium was replaced in human iPSC 110 medium containing Dulbecco's modified Eagle's medium: nutri-111 ent mixture F-12 (DMEM/F12; SIGMA, #D8900, St. Louis, MO, 112 USA) supplemented with 20% KnockOut serum replacement 113 (KSR; GIBCO, #10828-028, Waltham, MA, USA), 0.1 mM 2-114 mercaptoethanol (2-ME; SIGMA, M3148), 2 mM L-glutamine 115 (GIBCO, #25030-081), 0.1 mM nonessential amino acids 116 (NEAA; SIGMA, M7145, St. Louis, MO, USA), 0.5% penicillin 117 (Meiji, PGSD 1012, Tokyo, Japan) and streptomycin (Meiji, 118 SSDN), and 5 ng/ml basic fibroblast growth factor (bFGF; 119 WAKO, #060-04543, Osaka, Japan). Three weeks later, the 120 visualized colonies were picked up and re-cultured with MEFs 121 in the human iPSC medium. To remove the temperature-122 sensitive SeVs, the cells were cultured at 38°C for 3 days. 123 The iPSCs were maintained with MEFs in human iPSC 124 medium, and were harvested as needed with collagenase type 125 IV (GIBCO, #17104-019) for passaging. into the testes of 6-week old NOD/Shi-scid IL-2Rr-null immuno-133 deficient mice, and after 3 months, histological analyses were 134 performed as described previously (Hamasaki et al., 2012) . .
205

RNA isolation and PCR
206
RNA isolation and quantitative RT-PCR (qPCR) were per-207 formed as described previously (Hamasaki et al., 2012) . Briefly,
208
total RNAs were extracted according to the manufacturer's 209 instructions using an RNA-kit (QIAGEN, Hilden, Germany).
210
Then, the cDNAs were synthesized from the m-RNAs with Table   216 2 o . The qPCR was performed using the StepOnePlus real-time
217
PCR system (Applied Biosystems, Foster City, CA, USA). 
Measurement of HEXA activities 219 HEXA activity was measured as described previously , 2006) . Briefly, the cell lysate was fluorome-221 trically assayed for enzyme activity with 4- Harvested iPSCs were mixed with 1 ml STE (10 mM Tris-250 HCL pH 8.0, 10 mM EDTA pH 8.0, 150 mM NaCl) / protein 251 K (10 mg/ml) / 10% SDS (100:1:1 v/v/v) and were incubated 252 for 2 h at 55°C. After adding 800 μl phenol/chloroform and 253 mixing for 30 min, samples were centrifuged at 17,800 × g 254 for 10 min and collected the supernatant. After adding 255 800 μl isopropanol and mixing for 10 min, samples were 256 centrifuged at 17,800 × g for 10 min and then isopropanol 257 were removed completely. Pellets were eluted by TE buffer 258 with 10 μg/ml RNase and incubated for 1 h at 37°C. After 259 adding 400 μl phenol/chloroform and mixing for 30 min, 260 samples were centrifuged at 17,800 × g for 10 min and then 261 the supernatant were collected. After adding 40 μl 3 M 262 sodium acetate and 800 μl isopropanol and mixing for 263 10 min, samples were centrifuged at 17,800 × g for 264 10 min, and then the supernatant were removed. The pellet 265 was rinsed with 70% ethanol and resolved in 50 μl TE 266 buffer.
267 DNA sequencing 268 DNA sequencing was performed as described previously 269 (Hamasaki et al., 2012 
319 dH 2 O was added to give a final chloroform/methanol/dH 2 O 320 ratio of 1:2:1.4 (v/v/v). The tube was then centrifuged for 321 30 min at 2000 × g. Methanol (50% of the lower phase 322 volume) and 0.01 M KCl (20% of the total volume of the 323 lower phase plus methanol) were added to the lower phase, 324 then vortexed and centrifuged for 30 min at 2000 × g. These 325 two upper phases were combined and evaporated in a 326 rotary evaporator. The residue was dissolved in 2 ml of 327 0.1 M KCl and recycled three times on a Sepak C18 column 328 (Waters, Milford, MA, USA) (1 ml). The bound material was 329 eluted with 5 ml of chloroform/methanol (2:1 v/v) and 15 ml 330 of methanol. Those elutes were evaporated in a rotary eva-331 porator and re-suspended in 50% methanol as samples.
332
The HPLC was performed using an Agilent 1100 series 333 HPLC system (Santa Clara, CA, USA) consisting of a binary 334 pump, degasser, column heater (60°C), and refrigerated 335 auto-sampler (5°C). The samples or standards (10 μl) were 336 separated on a APS-2 hypersil hydrophilic column 337 (150 mm × 2.1 mm, 3 μm, Thermo Scientific) coupled to 338 an APS-2 guard column (10 mm × 2.1 mm inner diameter) 339 with an acetonitrile/ammonium acetate buffer gradient. The 340 eluates were then introduced into an Agilent 6470 Triple 341 Quadrupole Mass Spectrometer, and the total amounts of 342 GM2 ganglioside and other ganglioside classes were 343 measured.
FM1-43 imaging
345 FM1-43 imaging was used to examine the exocytotic activ-346 ity in neurons as described previously (Betz et al., 1992) . 347 The neurons were differentiated from the neural progenitors 348 derived from the iPSCs for 63-77 days on glass-bottom 349 dishes with NEM. The medium was changed to the dye-350 loading buffer, ACSF, containing 125 mM NaCl, 2.5 mM 351 KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 352 25 mM NaHCO 3 , and 25 mM glucose with 5 μM FM1-43 353 and the neurons were incubated for 30 min at 37°C. After 354 a further three washes with ACSF without FM1-43, the 355 fluorescence intensity of FM 1-43 was monitored using a 356 fluorescence microscope (DMi8, Leica, Wetzlar, Germany). 357 Excitation light (488 nm) was irradiated to the neural cells, 358 and fluorescence emitted at 520 nm was detected, with 359 50 mM KCl added into the samples under the microscope 360 to induce the membrane depolarization. The reduced fluor-361 escence intensity of the FM1-43 dye was determined by 362 comparing the stimulus intensity (after 8 s of stimulation) 363 to the basal (2 s before the stimulation). The intensity of 364 the FM emission was captured every second and saved 365 as a stacked image using the LAS X Imaging System 366 (Leica, Wetzlar, Germany). To confirm reproducibility, ima-367 ging experiments were performed at least three to five times 368 in an independent series of cultures. mas, suggesting that our iPSCs are multipotent (Fig. 1D ).
392
Both TSD-iPSCs, namely A56-#1 and A312-#1, carried 393 the mutation in HEXA gene, G to T substitution in the 3′-394 end of intron 5, which was previously reported as a common 395 type of Japanese (Fig. 1E ) (Tanaka et al., 1993 Q10 ). This muta-396 tion induced the abnormal splicing, resulting in the failure of
397
HEXA enzyme production (Tanaka et al., 1993) .
398
We concluded that our iPSCs fulfilled the criteria for 399 human iPSCs and were derived from TSD patients. Two 400 iPSCs lines, 201B7 and N2-1, were used as normal controls 401 in this study (Takahashi et al., 2007; Fujie et al., 2014 Fig. 2A-F   F2 ). The expression levels and proportions of 413 PAX6 and NESTIN were not decreased in TSD-derived
414
NPCs compared to those in normal NPCs ( Fig. 2A-E and 
415
G). The level of PAX6 mRNA was significantly lower in (Fig. 2G) . However, the level of PAX6 mRNA 418 was not low in N2-1-derived NPCs, another control (Fig.  419 2G) , and the expression levels of PAX6 protein in controls 420 were similar to those in TSDs ( Fig. 2A-E) . These results 421 indicated that the process of NPC generation was not 422 impaired in our in vitro TSD-derived iPSC cultures.
423 Characterization of the TSD-derived NPCs 424 TSD is caused by a loss of or significant reduction in the 425 enzyme activity of HEXA, which eventually accumulates 426 as GM2 ganglioside in the central nervous system 427 (Cachon-Gonzalez et al., 2018) . Accordingly, our TSD-428 derived NPCs exhibited low HEXA activity and significant 429 accumulation of GM2 ganglioside compared to normal 430 NPCs (Fig. 3A and B   F3 ). The ganglioside accumulation leads 431 to lysosome enlargement and the upregulation of lysosome 432 marker, LAMP1 (Wenger et al., 2002) . The lysosome size 433 was larger in our TSD-derived NPCs compared to normal 434 NPCs (Fig. 3C ) and LAMP1 expression was significantly 435 upregulated (Fig. 3D) , which is consistent with previous 436 results from TSD patients, suggesting that TSD-derived 437 NPCs mimicked the biochemical phenotypes of clinical 438 TSD. Both the enlargement of lysosome and the upregula-439 tion of LAMP1 expression were also detected in TSD lines 440 compared with another control line, N2-1, confirming our 441 results above (data not shown).
442
We next investigated markers of autophagy and cell 443 death due to oxidative stress in the NPCs. The expression 444 levels of autophagy markers including LC3B (Wu et al., 445 2006) and insoluble p62/SQSTM (p62) 446 were unchanged in NPCs derived from TSD-iPSCs com-447 pared to those of normal fibroblasts (Fig. 3E) , as was the 448 case for the TSD skin fibroblasts compared to normal skin 449 fibroblasts (Fig. 3E) . In contrast, the cell death with H 2 O 2 450 treatment, which was evaluated with WST-8 assay that cal-451 culates the cell viability as the mitochondrial dehydrogenase 452 activity, was significantly enhanced in TSD-NPCs com-453 pared to normal NPCs (Fig. 3F, G) . This suggested that 454 TSD-NPCs were less resistant to oxidative stress than nor-455 mal NPCs. and maintained the high level even on day 63 (Fig. 4A   F4 ).
465
To assess the synapse formation, we immunostained the 466 cultures with an antibody for synapsin I, a marker for 467 synapse formation (Hilfiker et al., 1999) . Despite these 468 MAP2 levels and the observation of neural morphology on 469 day 21, we were not able to detect the puncture of synapsin 470 I in the day-21 neurons (data not shown). After the long-term 471 culture (~70 days), we did detect synapsin I puncture, sug-472 gesting that synapse formation requires a longer time in our 473 system (Fig. 4B) . The synaptic puncture number on MAP2- (Fig. 4C) . The synaptic puncture 477 numbers were not different between TSDs and another nor-478 mal control, N2-1, suggesting that the increase was not spe-479 cific for TSD-derived neurons (Fig. 4C) . The TSD-derived 480 neurons showed similar neurite lengths to the control neu-481 rons (Fig. 4D) . Finally, as observed with the TSD-derived 482 NPCs, TSD-derived neurons significantly accumulated 483 GM2 ganglioside (Fig. 4E) . Together, these results suggest (Fig. 4F) , whereas 496 the decrease was greatly diminished in TSD-derived neu-497 rons even following depolarization (Fig. 4F, G) . These 498 results suggested that TSD-derived neurons lose the poten-499 tial for exocytosis at their synaptic terminal.
500
DISCUSSION
501
In this study, we generated TSD-iPSCs from the patient skin and TSD-NPCs (A56 #1 and A312 #1) (n = 6 in each cell line, mean ± SD). The viability was measured by WST8 assay. *P < 0.05, **P < 0.01, ***P < 0.001, Student's t-test. (G) Cell viability treated with 50 μM or 100 μM H 2 O 2 in the normal (N2-1) and TSD-NPCs (A56 #1) (n = 6 in each cell line, mean ± SD). The viability was measured by WST8 assay. ***P < 0.001 indicates the TSD-versus normal NPCs, Student's t-test. 
normal NPCs, as well as similar neurite lengths during dif-506 ferentiation. Further, the disease-specific alteration was 507 not consistently observed in the number of synaptic sites 508 determined by immunostaining for synapsin I. These results 509 suggest that the TSD-iPSCs have a similar potential to dif-510 ferentiate into mature neurons compared to healthy-donor 511 iPSCs.
512
Functional analysis also revealed decreased exocytotic 513 activity in the neurons derived from TSD-iPSCs compared 514 with normal, shown by a slower loss of FM1-43 intensity 515 at depolarization (Betz et al., 1992) , suggesting impaired 516 neurotransmission. Presynaptic exocytosis is critical at the 517 synaptic site for signal transduction to postsynaptic neu-518 rons, and its disturbance affects the overall neural network 519 activity (Brewer et al., 2009; Lepeta et al., 2016 Q11 ). The clini-520 cal symptoms of neural disturbance in TSD have been 521 attributed to the accumulation of GM2 ganglioside in neu-522 rons, leading to early cell death (Huang et al., 1997) . Con-523 sistently, oxidative stress induced by H 2 O 2 treatment 524 enhanced neural cell death in the TSD-NPCs. Our results 525 thus corroborate previous evidence and are consistent with 526 the clinical symptoms of TSD.
527
We confirmed GM2 ganglioside accumulation in the 528 NPCs and neurons derived from TSD-iPSCs, and accord-529 ingly, the neural progenitors derived from TSD-iPSCs 530 showed larger lysosomes than those from healthy-donor-531 iPSCs. LAMP1 expression was also upregulated in the 532 neural progenitors derived from TSD-iPSCs compared with 533 those from healthy-donor-iPSCs. In lysosomal diseases, the 534 intermediates of metabolism accumulate in lysosomes, 535 increasing both their size and marker expression such as 536 LAMP1 (Wenger et al., 2002) . The disrupted HEXA enzyme 537 activity in TSD would impair the digestion from GM2 to GM3 538 gangliosides, accounting for the general neuronal increase 539 in GM2 ganglioside accumulation (Cachon-Gonzalez et 540 al., 2018) . Thus, our results indicate that neural cells 541 derived from TSD-iPSCs mirror the biochemical phenotype 542 of TSD.
543
Significant upregulation of GM2 ganglioside in both TSD-544 NPCs and -neurons observed in the present study raises a 545 question regarding a relationship between such an increase 546 of GM2 ganglioside and repression in exocytotic activity. It 547 has been demonstrated that blockade of lysosomal degra-548 dation activity by protease inhibitors such as leupeptin or 549 pepstatin A causes a lysosomal enlargement accompanied 550 with inefficient endocytotic/exocytotic events in mouse pri-551 mary hippocampal cultures (Sambri et al., 2017 (Okada et al., 1970) ; thus, our in vitro system using 557 differentiated human neurons from PAX6 (a marker for dor-558 sal telencephalon (Kim et al., 2014) (Pacheco et al., 2007; Keilani et al., 2012) . It is possible that ). The skin fibroblast used in previous studies is largely 582 unaffected in clinical TSD, while the HexA-null mouse dis-583 played a similar phenotype to wild type and showed no early 584 death in young adults even without HexA activity (Sango et 585 al., 1995; Taniike et al., 1995) . This discrepancy between 586 mouse and human may be due to a murine-specific siali-587 dase, Neu3, which can bypass the GM2 metabolism path-588 way by digesting GM2 to GA2 gangliosides (Sango et al., 589 1995; Martino et al., 2009) . Although other groups recently 590 generated TSD-iPSCs from patient fibroblasts, they did not 591 evaluate the synaptic function in vitro (Vu et al., 2015; Liu 592 and Zhao, 2016). Modern iPSC technology is now used in -stimulated one -fading value, mean ± SD). ***P < 0.001, Student's t-test. (G) Presynaptic function in another normal control, N2-1, and TSD neurons. Exocytotic activity of functional neurons on day 70 was monitored with imaging using FM 1-43. Experiment was described in (F). **P < 0.01, ***P < 0.001, Student's t-test. (Soga et al., 2015; Hino et al., 596 2017; Imamura et al., 2017) . Our neural cells derived from 597 TSD-iPSCs might contribute to drug discovery research as 598 good candidates for candidate screening, and the model 599 established here also provides insights into the mechanism 600 underlying synaptic dysfunction in TSD. 
